Influence of erythromycin pre- and co-treatment on single-dose pharmacokinetics of the HMG-CoA reductase inhibitor cerivastatin

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1994 • 8,631 citations

PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA

1995 • 3,524 citations

Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid

1996 • 241 citations

Macrolide Antibacterials

1995 • 206 citations

Biotransformation of lovastatin

1991 • 195 citations

In vitro comparative inhibition profiles of major human drug metabolising cytochrome P450 isozymes (CYP2C9, CYP2D6 and CYP3A4) by HMG-CoA reductase inhibitors

1996 • 178 citations

Plasma Concentration Profiles of Simvastatin 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitory Activity in Kidney Transplant Recipients with and without Ciclosporin

1993 • 138 citations

Altered disposition of pravastatin following concomitant drug therapy with cyclosporin A in transplant recipients.

1993 • 113 citations

Rhabdomyolysis associated with lovastatin and erythromycin use.

1991 • 83 citations

The rational selection of drug interaction studies: implications of recent advances in drug metabolism.

1992 • 72 citations

Low-dose lovastatin safely lowers cholesterol after cardiac transplantation.

1990 • 69 citations

Cerivastatin, a New Potent Synthetic HMG Co-A Reductase Inhibitor: Effect of 0.2 mg Daily in Subjects With Primary Hypercholesterolemia

1997 • 53 citations

Absolute and relative bioavailability of the HMG-CoA reductase inhibitor cerivastatin.

1997 • 51 citations

Influence of the antacid Maalox and the H2-antagonist cimetidine on the pharmacokinetics of cerivastatin.

1997 • 30 citations

BAY W 6228

1994 • 28 citations

LC separation and induced fluorometric detection of rivastatin in blood plasma

1993 • 26 citations